Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Abroad (travel likely)RecruitingPHASE3

Conditions

Advanced Hepatocellular Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Palo Alto Medical Foundation-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Caressa Hui)
  • Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Caressa Hui)
  • Palo Alto Medical Foundation Health Care, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Edward J. Kim)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Sutter Pacific Medical Foundation, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org · 415-209-2683
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Jorge A. Garcia-Young)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Joshua H. Petit)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Joshua H. Petit)
  • Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ccrp@co-cancerresearch.org · 303-777-2663
    Contact: Principal Investigator (Lucas Gilbride)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Joshua H. Petit)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Joshua H. Petit)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital-Hamden Care Center, Hamden, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Kevin L. Du)
  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Soumon Rudra)
  • Emory Proton Therapy Center, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · allyson.anderson@emory.edu · 404-251-2854
    Contact: Principal Investigator (Soumon Rudra)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Soumon Rudra)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Soumon Rudra)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Soumon Rudra)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Joseph Franses)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Joseph Franses)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Joseph Franses)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Benjamin R. Tan)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Joseph Franses)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Cancer Center-West Lakes, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Greater Regional Medical Center, Creston, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • The Iowa Clinic PC, West Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-875-9815
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-257-3379
    Contact: Principal Investigator (Mark E. Bernard)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Parag J. Parikh)
  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Parag J. Parikh)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Miller-Dwan Hospital, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Benjamin R. Tan)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Benjamin R. Tan)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Benjamin R. Tan)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Benjamin R. Tan)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Benjamin R. Tan)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Benny J. Liem)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Michael H. Buckstein)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Byung-Han Rhieu)
  • Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Byung-Han Rhieu)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Eric D. Miller)
  • Clackamas Radiation Oncology Center, Clackamas, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Austin J. Iovoli)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Austin J. Iovoli)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Austin J. Iovoli)
  • Inova Alexandria Hospital, Alexandria, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-776-2580
    Contact: Principal Investigator (Grace Lee)
  • Inova Schar Cancer Institute, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Grace Lee)
  • Inova Fair Oaks Hospital, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Grace Lee)
  • Inova Fairfax Hospital, Falls Church, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-208-6650
    Contact: Principal Investigator (Grace Lee)
  • Inova Loudoun Hospital, Leesburg, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Keary.janet@inova.org · 703-858-6000
    Contact: Principal Investigator (Grace Lee)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Anderson A. Bauer)
  • Essentia Health-Hayward Clinic, Hayward, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Anderson A. Bauer)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Anderson A. Bauer)
  • Essentia Health-Spooner Clinic, Spooner, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Anderson A. Bauer)
  • Essentia Health Saint Mary's Hospital - Superior, Superior, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 701-364-6272
    Contact: Principal Investigator (Bret E. Friday)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Anderson A. Bauer)
Study leads
  • Jennifer Y Wo

    Principal Investigator

    NRG Oncology